Switch theme
Sign up to access all valuation multiples
Redwood Scientific Technologies Inc is a pharmaceutical delivery company that develops, operates, and markets over-the-counter products in a sublingual oral thin film strip. RSCI has begun clinical trials on two new products to market for stopping the addiction to nicotine.
1986
3
LTM Revenue n/a
LTM EBITDA n/a
$28.3M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Redwood Scientific Technologies has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Redwood Scientific Technologies achieved revenue of n/a and an EBITDA of -$3.5M.
Redwood Scientific Technologies expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Redwood Scientific Technologies valuation multiples based on analyst estimates| FY 2022 | FY 2023 | FY 2024 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | n/a | XXX |
| Gross Profit | n/a | n/a | n/a | XXX | XXX |
| Gross Margin | NaN% | NaN% | NaN% | XXX | XXX |
| EBITDA | n/a | -$0.1M | -$3.5M | n/a | XXX |
| EBITDA Margin | NaN% | -Infinity% | -Infinity% | NaN% | XXX |
| Net Profit | n/a | -$0.1M | -$3.5M | XXX | XXX |
| Net Margin | NaN% | -Infinity% | -Infinity% | XXX | XXX |
| Net Debt | n/a | n/a | n/a | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of February 21, 2025, Redwood Scientific Technologies's stock price is $0.
Redwood Scientific Technologies has current market cap of $28.6M, and EV of $28.3M.
See Redwood Scientific Technologies trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $28.3M | $28.6M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of February 21, 2025, Redwood Scientific Technologies has market cap of $28.6M and EV of $28.3M.
Redwood Scientific Technologies's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Redwood Scientific Technologies's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Redwood Scientific Technologies and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $28.3M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | XXX | XXX |
| EV/EBITDA | -8.1x | XXX | XXX | XXX |
| P/E | -8.2x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -24.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpRedwood Scientific Technologies's NTM/LTM revenue growth is n/a
Redwood Scientific Technologies's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged $1.2M for the same period.
Over next 12 months, Redwood Scientific Technologies's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Redwood Scientific Technologies's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Redwood Scientific Technologies and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
| EBITDA Growth | 2323% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | $1.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | n/a | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| LTR Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Starpharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Schott Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Nanoform | XXX | XXX | XXX | XXX | XXX | XXX |
| Peptron | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Redwood Scientific Technologies acquired XXX companies to date.
Last acquisition by Redwood Scientific Technologies was XXXXXXXX, XXXXX XXXXX XXXXXX . Redwood Scientific Technologies acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Redwood Scientific Technologies founded? | Redwood Scientific Technologies was founded in 1986. |
| Where is Redwood Scientific Technologies headquartered? | Redwood Scientific Technologies is headquartered in United States of America. |
| How many employees does Redwood Scientific Technologies have? | As of today, Redwood Scientific Technologies has 3 employees. |
| Is Redwood Scientific Technologies publicy listed? | Yes, Redwood Scientific Technologies is a public company listed on PINX. |
| What is the stock symbol of Redwood Scientific Technologies? | Redwood Scientific Technologies trades under RSCI ticker. |
| Who are competitors of Redwood Scientific Technologies? | Similar companies to Redwood Scientific Technologies include e.g. LTR Pharma, Starpharma, Schott Pharma, Nanoform. |
| What is the current market cap of Redwood Scientific Technologies? | Redwood Scientific Technologies's current market cap is $28.6M |
| Is Redwood Scientific Technologies profitable? | Yes, Redwood Scientific Technologies is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
